Arhaus (ARHS) is a Consumer Cyclical company in the Specialty Retail industry. It has a market capitalization of $2.01B, a trailing price-to-earnings ratio of 30.9 and a free-cash-flow yield of 3.0%. Over the most recent reported fiscal year, revenue grew 8.5% and free cash flow per share grew 47.7%. Nama's AI scorecard rates it Sell, 3.4 out of 10. On 12-month momentum it ranks in the middle band of its market.
AI scorecard
Sell · 3.4/10
Negative, at the mild end of Sell. As of Nov 7, 2026.
Momentum
Middle · +4.7% over 12 months ex. last
Middle fifth of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-28.4%
How far the last close sits under the highest price of the past five years.
Market cap
$2.01B
Trailing P/E
30.9
Price / book
4.8
Price / sales
1.4
FCF yield
3.0%
Dividend yield
—
Gross margin
39.7%
Operating margin
6.6%
Net margin
4.9%
Revenue growth (YoY)
+8.5%
Revenue growth (3-yr annual)
+3.9%
EPS growth (YoY)
-2.0%
FCF/share growth (YoY)
+47.7%
Beta
2.3
Exchange
NASDAQ
Sector
Consumer Cyclical
Industry
Specialty Retail
ARHS earnings
Next report: Feb 25, 2027 (Q4 2026, EPS estimate $0.15).
Beat the EPS estimate in 2 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Nov 5, 2026
$0.05
$0.09
-44.4%
$368.12M
Q2 2026
Aug 6, 2026
$0.28
$0.16
+75.0%
$384.90M
Q1 2026
May 7, 2026
$0.02
$0.02
+0.0%
$314.28M
Q4 2025
Feb 26, 2026
$0.11
$0.09
+22.2%
$364.85M
ARHS analyst price target
Median target $11.00 from 13 analysts, ranging $9.00 – $13.50.
Nama's AI scorecard currently rates Arhaus Sell (3.4 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is ARHS's P/E ratio?
Arhaus trades at a trailing price-to-earnings ratio of 30.9.
When does ARHS report earnings?
Arhaus's next scheduled report is on Feb 25, 2027. Analysts expect EPS of $0.15.
What is the ARHS price target?
The median analyst price target from 13 analysts is $11.00, with a range of $9.00 – $13.50.
Is ARHS Shariah compliant?
Nama's AAOIFI-style screen reads Arhaus as Not Shariah Compliant. At least one of the three ratios or the industry test failed.